2011
DOI: 10.1016/j.jval.2011.08.082
|View full text |Cite
|
Sign up to set email alerts
|

PMD9 A1CNow® as Ambulatory Monitoring of Glycated Hemoglobin in Diabetic Type 2 (DM2) Patients: Systematic Review

Abstract: data about the manner in which PAM visualizes different tumor types. CONCLUSIONS: Using expert elicitation prior distributions for sensitivity and specificity of PAM were obtained. This evidence could be used in early health economic models to establish cost-effectiveness. However, experts expressed difficulties estimating the performance based on limited data. The expression of uncertainty surrounding their beliefs reflects the infancy of the diagnostic method, however further clinical trials should be commis… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles